Oxytetracycline: adverse event reports in all combinations
Active ingredient, alone and in combinations
Brand names with this ingredient: Oxyject, MGA and TM, Bio-Mycin, OXY-TET, Neo-Terramycin, Terramycin, and 12 more.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Read this first. FDA says this about the data:
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .
This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.
Contacting a veterinarianHow to report to FDAFDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.
From April 1987 to June 2026, FDA received 1,830 adverse event reports that name a drug with oxytetracycline, alone or in a combination. 3 sets of active ingredients with oxytetracycline have a drug page.
Of the 1,830 reports, 737 (40.3%) are about cattle. 228 reports are about cats (12.5%). In January to March 2026, FDA received 4 reports that name oxytetracycline, alone or in a combination. The signs that appear in the largest number of the 1,830 reports are "Death", "Anaphylaxis" and "Solution, Abnormal". A report is not proof that a drug caused a sign.
Reports that name this ingredient fell by 26.2% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about dogs are 5.1% of the reports that name this ingredient, and 72.6% of all reports.
Reports in the latest closed quarter
| Species | Jan to Mar 2026 | Oct to Dec 2025 | Jan to Mar 2025 |
|---|---|---|---|
| All species | 4 | 10 | 10 |
| Dog | 1 | 1 | 1 |
| Cat | 0 | 0 | 6 |
| Horse | 1 | 1 | 0 |
| Other or not given | 2 | 8 | 3 |
January to March 2026 is the latest closed quarter in the data.
Drug pages with oxytetracycline
A report names a drug by its set of active ingredients. Each set with oxytetracycline that has a drug page is in the table, in order of name. The table has 3 sets.
| Active ingredients | Reports, all years | Reports, latest 12 months |
|---|---|---|
| Oxytetracycline | 1,242 | 13 |
| Oxytetracycline + Oxytetracycline Dihydrate | 165 | 3 |
| Oxytetracycline + Polymyxin B Sulfate | 389 | 15 |
A report can name more than one set, so the counts of the sets can add to more than the count of the page.
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
Signs that the reports list
A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 1,830 reports that list the sign. One report can list more than one sign and more than one drug.
The sign that is in the largest number of the reports comes first.
- Death21%385 reports
- Anaphylaxis[sudden severe allergic-type reaction]11.6%212 reports
- Solution, Abnormal[a product quality report, not a sign in an animal]10.5%192 reports
- Color, Abnormal[a product quality report, not a sign in an animal]9.9%182 reports
- Injection site swelling[swelling where the injection was given]8.5%156 reports
- Lack of efficacy (bacteria) - NOS[the product did not have the expected effect: target not specified]8%146 reports
- Collapse4.8%88 reports
- Dyspnoea[difficulty breathing]3.9%72 reports
- Hypersalivation[drooling]3.2%58 reports
- Vomiting2.8%52 reports
- Accidental exposure[exposure that was not intended]2.8%51 reports
- Injection site pain[pain where the injection was given]2.6%48 reports
- Unclassifiable adverse event[event that fits no dictionary term]2.6%48 reports
- Lack of efficacy - NOS[the product did not have the expected effect]2.5%45 reports
Show the next 16 signs
- No sign[no clinical sign was reported]2.4%44 reports
- Anorexia[not eating]2.3%43 reports
- Recumbency[lying down and unable or unwilling to rise]2.3%43 reports
- Eyelid oedema2.1%39 reports
- Containers, Damaged[a product quality report, not a sign in an animal]1.9%34 reports
- Diarrhoea[diarrhea]1.9%34 reports
- Death by euthanasia[the animal was euthanized]1.8%33 reports
- Depression[dull, quiet or withdrawn]1.7%32 reports
- Containers, Leaking[a product quality report, not a sign in an animal]1.7%31 reports
- Fever1.6%30 reports
- Lethargy[unusually tired or inactive]1.6%30 reports
- Residues in milk1.5%28 reports
- Vials, Leaking[a product quality report, not a sign in an animal]1.5%27 reports
- Lameness1.4%25 reports
- Injection site abscess[abscess where the injection was given]1.3%24 reports
- Vials, Damaged[a product quality report, not a sign in an animal]1.3%24 reports
Reports by species
Reports for each month, Jul 2021 to Jun 2026
No chart: no month has 5 or more reports.
No chart: no month has 5 or more reports.
The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
Reports by year
- Dog
- Cat
- Horse
- Other or not given
| Year | Dog | Cat | Horse | Other or not given | All species |
|---|---|---|---|---|---|
| 2026 | 2 | 2 | 1 | 3 | 8 |
| 2025 | 3 | 14 | 2 | 23 | 42 |
| 2024 | 3 | 16 | 0 | 28 | 47 |
| 2023 | 3 | 20 | 1 | 12 | 36 |
| 2022 | 6 | 12 | 0 | 24 | 42 |
| 2021 | 2 | 7 | 0 | 37 | 46 |
| 2020 | 6 | 11 | 1 | 71 | 89 |
| 2019 | 2 | 11 | 1 | 41 | 55 |
| 2018 | 3 | 11 | 3 | 35 | 52 |
| 2017 | 3 | 7 | 3 | 46 | 59 |
| 2016 | 2 | 8 | 0 | 51 | 61 |
| 2015 | 8 | 10 | 3 | 27 | 48 |
| 2014 | 4 | 4 | 0 | 36 | 44 |
| 2013 | 4 | 6 | 2 | 29 | 41 |
| 2012 | 3 | 2 | 1 | 30 | 36 |
| 2011 | 3 | 7 | 4 | 42 | 56 |
| 2010 | 3 | 3 | 2 | 44 | 52 |
| 2009 | 2 | 8 | 2 | 35 | 47 |
| 2008 | 3 | 9 | 2 | 42 | 56 |
| 2007 | 3 | 5 | 11 | 129 | 148 |
| 2006 | 2 | 6 | 1 | 94 | 103 |
| 2005 | 4 | 1 | 1 | 102 | 108 |
| 2004 | 2 | 7 | 2 | 64 | 75 |
| 2003 | 1 | 4 | 1 | 62 | 68 |
| 2002 | 5 | 4 | 1 | 21 | 31 |
| 2001 | 3 | 12 | 0 | 28 | 43 |
| 2000 | 2 | 7 | 1 | 55 | 65 |
| 1999 | 1 | 3 | 0 | 30 | 34 |
| 1998 | 2 | 6 | 1 | 50 | 59 |
| 1997 | 1 | 1 | 0 | 22 | 24 |
| 1996 | 2 | 1 | 1 | 45 | 49 |
| 1995 | 0 | 3 | 0 | 23 | 26 |
| 1994 | 0 | 0 | 0 | 14 | 14 |
| 1993 | 0 | 0 | 0 | 16 | 16 |
| 1992 | 0 | 0 | 0 | 11 | 11 |
| 1991 | 0 | 0 | 1 | 17 | 18 |
| 1990 | 0 | 0 | 0 | 8 | 8 |
| 1989 | 0 | 0 | 0 | 5 | 5 |
| 1988 | 0 | 0 | 0 | 1 | 1 |
| 1987 | 0 | 0 | 0 | 7 | 7 |
2026 has the reports that FDA received through Jun 2026. Download the years (CSV)
What the reports record
Outcome at the time of the report
- Recovered/Normal7.4%135
- Recovered with Sequela[recovered, with a lasting effect]0.4%8
- Ongoing5.8%106
- Died24.3%445
- Euthanized1.3%23
- Outcome Unknown7.6%139
An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 1,830 reports that name oxytetracycline.
Kind of report
- Safety issue64.3%1,176
- Lack of expected effectiveness2.8%52
- Both safety and lack of expected effectiveness1.4%26
- Manufacturing or product defect31.5%576
- Other0%0
Age of the animal
- Under 1 year18%329
- 1 to 3 years13%238
- 4 to 7 years5.5%101
- 8 to 11 years3%55
- 12 years and over4.6%84
- Age not given55.9%1,023
Each share of kind and age is of the 1,830 reports that name oxytetracycline.
Approved animal drugs with this active ingredient (FDA Green Book)
This section is reference data. It has no report count.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Brand names
- Oxyject
- MGA and TM
- Bio-Mycin
- OXY-TET
- Neo-Terramycin
- Terramycin
- Status SQ
- Medamycin
- Liquamycin LA-200
- Pennox
- Hexasol
- Maxim 100
The Green Book has 6 more brand names with this active ingredient. Brand names A to Z
What the Green Book records give
- Applications with an approval in force
- 24
- Approved species
- Cattle, Swine, Chickens, Sheep, Turkeys, Bees
- Dose forms
- Type A Medicated Article, Injectable Solution, Liquid (Solution), Type A medicated articles to be used in the manufacture of Type C medicated feeds
- Routes
- Oral, Intramuscular, Intravenous, Subcutaneous
- Sale
- VFD (veterinary feed directive), RX (prescription)
- Earliest approval date in the records
The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.
| Brand name | Active ingredients | Sponsor | Approved species | Application |
|---|---|---|---|---|
| Oxyject | Oxytetracycline | Cronus Pharma Specialities India Private Ltd. | Cattle | NADA 045-143 |
| MGA and TM | Melengestrol Acetate, Oxytetracycline | Phibro Animal Health Corp. | Cattle | NADA 046-718 |
| MGA and TM | Melengestrol Acetate, Oxytetracycline | Phibro Animal Health Corp. | Cattle | NADA 046-719 |
| Bio-Mycin; OXY-TET 50 | Oxytetracycline | Cronus Pharma Specialities India Private Ltd. | Cattle, Swine | NADA 047-278 |
| Neo-Terramycin 100/100; Neo-Terramycin 100/100D; Neo-Terramycin 50/50; Neo-Terramycin 50/50D | Neomycin Sulfate, Oxytetracycline | Phibro Animal Health Corp. | Cattle, Swine, Chickens, Turkeys, Sheep | NADA 094-975 |
| Terramycin 10; Terramycin 30; Terramycin 50; Terramycin 100; Terramycin 200; Terramycin 200 Granular; Terramycin 100MR | Oxytetracycline | Phibro Animal Health Corp. | Cattle, Swine, Chickens, Turkeys, Sheep | NADA 095-143 |
| Oxyject 100; Status SQ | Oxytetracycline | Cronus Pharma Specialities India Private Ltd. | Cattle, Swine | NADA 097-452 |
| Coban/TM | Monensin, Oxytetracycline | Phibro Animal Health Corp. | Chickens | NADA 099-006 |
| TM plus Robenz | Oxytetracycline, Robenidine Hydrochloride | Phibro Animal Health Corp. | Chickens | NADA 101-666 |
| Medamycin 100; Medamycin | Oxytetracycline | Cronus Pharma Specialities India Private Ltd. | Cattle | NADA 108-963 |
| Liquamycin LA-200 | Oxytetracycline | Zoetis Inc. | Cattle, Swine | NADA 113-232 |
| Pennox 50; Pennox 100-MR; Pennox 100 Hi-Flo; Pennox 200 Hi-Flo | Oxytetracycline | Pharmgate Inc. | Cattle, Swine, Chickens, Turkeys, Sheep | NADA 138-938 |
| TM plus Bio-Cox | Oxytetracycline, Salinomycin Sodium | Phibro Animal Health Corp. | Chickens | NADA 140-448 |
| Mecadox and Terramycin | Carbadox, Oxytetracycline | Phibro Animal Health Corp. | Swine | NADA 141-211 |
| Hexasol Injection | Flunixin Meglumine, Oxytetracycline | Norbrook Laboratories, Ltd. | Cattle | NADA 141-312 |
| Bio-Mycin 200 | Oxytetracycline | Boehringer Ingelheim Animal Health USA, Inc. | Cattle, Swine | ANADA 200-008 |
| Maxim 100 | Oxytetracycline | Huvepharma EOOD | Cattle | ANADA 200-068 |
| Sacox / Terramycin | Oxytetracycline, Salinomycin Sodium | Huvepharma EOOD | Chickens | ANADA 200-096 |
| Oxytetracycline Injection | Oxytetracycline | Bimeda Animal Health Ltd. | Cattle, Swine | ANADA 200-117 |
| MAXIM-200 | Oxytetracycline | Huvepharma EOOD | Cattle, Swine | ANADA 200-123 |
| Pennox 200 | Oxytetracycline | Pharmgate Inc. | Cattle, Swine | ANADA 200-154 |
| Oxytetracycline Injection 200 | Oxytetracycline | Norbrook Laboratories, Ltd. | Cattle, Swine | ANADA 200-306 |
| Oxytet 100 | Oxytetracycline | Norbrook Laboratories, Ltd. | Cattle | ANADA 200-452 |
| Tetroxy-LA | Oxytetracycline | Bimeda Animal Health Ltd. | Cattle, Swine | ANADA 200-537 |
| Geomycin 200approval withdrawn | Oxytetracycline | Pliva, d. d. | Cattle, Swine | ANADA 200-232 |
FDA pages for this ingredient
- How to Report Animal Drug and Device Side Effects and Product ProblemsThe FDA page that tells an owner or a veterinarian how to send a report.
- Green Book record of NADA 045-143The FDA record of the application for Oxyject.
- Green Book record of NADA 046-718The FDA record of the application for MGA and TM.
- Green Book record of NADA 046-719The FDA record of the application for MGA and TM.
- Green Book record of NADA 047-278The FDA record of the application for Bio-Mycin, OXY-TET 50.
- Green Book record of NADA 094-975The FDA record of the application for Neo-Terramycin 100/100, Neo-Terramycin 100/100D, Neo-Terramycin 50/50, Neo-Terramycin 50/50D.
- Green Book record of NADA 095-143The FDA record of the application for Terramycin 10, Terramycin 30, Terramycin 50, Terramycin 100, Terramycin 200, Terramycin 200 Granular, Terramycin 100MR.
- Animal Drugs @ FDAThe search page of the Green Book, the FDA list of approved animal drugs.
The site checked these addresses on . The links open in a new tab.
Cite this page
Pet Drug Reports. Oxytetracycline, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/oxytetracycline/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .
Where the data come from
The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.
The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.
Questions about these reports
- Which brand are these reports about?
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists brand names with this active ingredient.
- Do the reports show that the ingredient caused the signs?
No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.
When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.
The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
- How many reports did FDA receive in the latest 12 months?
FDA received 31 reports in the 12 months to June 2026. It received 42 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
- What kinds of report are in the count?
Of the 1,830 reports received from April 1987 to June 2026, 64.3% are about a safety issue only. 4.3% are about a lack of expected effectiveness, alone or with a safety issue. 31.5% are about a defect of the product or its package.